Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Masayuki Matsukura
Observed names:
M. MATSUKURA,
Masayuki MATSUKURA
Institution:
Eisai (Japan)
Observed institution:
Eisai (Japan)
OpenAlex ID:
A5041422487
Lenvatinib, an angiogenesis inhibitor targeting VEGFR/FGFR, shows broad antitumor activity in human tumor xenograft models associated with microvessel density and pericyte coverage
2014
·
Yuji Yamamoto
, Junji Matsui
, et al.
·
Vascular Cell
·
518
PDF
4-Benzylamino-1-chloro-6-substituted Phthalazines: Synthesis and Inhibitory Activity toward Phosphodiesterase 5
1998
·
Nobuhisa Watanabe
, Yasuhiro Kabasawa
, et al.
·
Journal of Medicinal Chemistry
·
215
In Vitro Activity of E1210, a Novel Antifungal, against Clinically Important Yeasts and Molds
2011
·
Mamiko Miyazaki
, Takaaki Horii
, et al.
·
Antimicrobial Agents and Chemotherapy
·
205
PDF
Efficacy of Oral E1210, a New Broad-Spectrum Antifungal with a Novel Mechanism of Action, in Murine Models of Candidiasis, Aspergillosis, and Fusariosis
2011
·
Katsura Hata
, Takaaki Horii
, et al.
·
Antimicrobial Agents and Chemotherapy
·
156
2-Alkynyl-8-aryl-9-methyladenines as Novel Adenosine Receptor Antagonists: Their Synthesis and Structure−Activity Relationships toward Hepatic Glucose Production Induced via Agonism of the A2BReceptor
2000
·
Hitoshi Harada
, Osamu Asano
, et al.
·
Journal of Medicinal Chemistry
·
113
E7386, a Selective Inhibitor of the Interaction between β-Catenin and CBP, Exerts Antitumor Activity in Tumor Models with Activated Canonical Wnt Signaling
2021
·
Kazuhiko Yamada
, Yusaku Hori
, et al.
·
Cancer Research
·
71
Synthesis and evaluation of novel antifungal agents-quinoline and pyridine amide derivatives
2010
·
Kazutaka Nakamoto
, Itaru Tsukada
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
47
Synthesis and Antiarrhythmic Activity of 2,2-Dialkyl-1'-(N-substituted aminoalkyl)-spiro-(chroman-4,4'-imidazolidine)-2',5'-diones.
1992
·
Masayuki MATSUKURA
, Yoshiharu DAIKU
, et al.
·
Chemical and Pharmaceutical Bulletin
·
47
PDF
Synthesis of (2R)-1-(4-Chloro-2-pyridyl)-2-(2-pyridyl)ethylamine: A Selective Oxime Reduction and Crystallization-Induced Asymmetric Transformation
1996
·
Shigeto Negi
, Masayuki Matsukura
, et al.
·
Synthesis
·
46
4-(3-Chloro-4-methoxybenzyl)aminophthalazines: Synthesis and Inhibitory Activity toward Phosphodiesterase 5
2000
·
Nobuhisa Watanabe
, Hideyuki Adachi
, et al.
·
Journal of Medicinal Chemistry
·
44
Ten-Gram-Scale Total Synthesis of the Anticancer Drug Candidate E7130 to Supply Clinical Trials
2024
·
Yosuke Kaburagi
, Kazunobu Kira
, et al.
·
Organic Letters
·
15
An Effective Synthesis of a (Pyridin-3-yl)isoxazole via 1,3-Dipolar Cycloaddition Using ZnCl2: Synthesis of a (2-Aminopyridin-3-yl)isoxazole Derivative and Its Antifungal Activity
2010
·
Keigo Tanaka
, Satoshi Inoue
, et al.
·
Chemistry Letters
·
15
What Does It Take to Develop Structurally Complex Molecules by Total Synthesis? Rapid Process Development and GMP Manufacturing of E7130 Drug Substance for First-in-Human Clinical Study
2024
·
Takeo Sasaki
, Kenzo Yahata
, et al.
·
Organic Process Research & Development
·
11
Discovery and development of aryl-fused imidazole-based angiotensin II antagonists
1994
·
Kazutoshi Miyake
, Masayuki Matsukura
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
7
Abstract 5177: E7386 : First-in-class orally active CBP/beta-catenin modulator as an anticancer agent
2017
·
Kazuhiko Yamada
, Yusaku Hori
, et al.
·
Cancer Research
·
6
Data from E7386, a Selective Inhibitor of the Interaction between β-Catenin and CBP, Exerts Antitumor Activity in Tumor Models with Activated Canonical Wnt Signaling
2023
·
Kazuhiko Yamada
, Yusaku Hori
, et al.
Supplementary Materials and Methods from E7386, a Selective Inhibitor of the Interaction between β-Catenin and CBP, Exerts Antitumor Activity in Tumor Models with Activated Canonical Wnt Signaling
2023
·
Kazuhiko Yamada
, Yusaku Hori
, et al.
Supplementary Table S2 from E7386, a Selective Inhibitor of the Interaction between β-Catenin and CBP, Exerts Antitumor Activity in Tumor Models with Activated Canonical Wnt Signaling
2023
·
Kazuhiko Yamada
, Yusaku Hori
, et al.
Supplementary Table S3 from E7386, a Selective Inhibitor of the Interaction between β-Catenin and CBP, Exerts Antitumor Activity in Tumor Models with Activated Canonical Wnt Signaling
2023
·
Kazuhiko Yamada
, Yusaku Hori
, et al.
Supplementary Tables from E7386, a Selective Inhibitor of the Interaction between β-Catenin and CBP, Exerts Antitumor Activity in Tumor Models with Activated Canonical Wnt Signaling
2023
·
Kazuhiko Yamada
, Yusaku Hori
, et al.
Supplementary Figures from E7386, a Selective Inhibitor of the Interaction between β-Catenin and CBP, Exerts Antitumor Activity in Tumor Models with Activated Canonical Wnt Signaling
2023
·
Kazuhiko Yamada
, Yusaku Hori
, et al.
ChemInform Abstract: 4‐Benzylamino‐1‐chloro‐6‐Substituted Phthalazines: Synthesis and Inhibitory Activity Toward Phosphodiesterase 5.
1998
·
N. WATANABE
, Y. KABASAWA
, et al.
·
ChemInform
ChemInform Abstract: Synthesis of (2R)‐1‐(4‐Chloro‐2‐pyridyl)‐2‐(2‐pyridyl)ethylamine: A Selective Oxime Reduction and Crystallization‐Induced Asymmetric Transformation.
1996
·
S. NEGI
, M. MATSUKURA
, et al.
·
ChemInform
ChemInform Abstract: Discovery and Development of Aryl‐Fused Imidazole‐Based Angiotensin II Antagonists
1994
·
K. MIYAKE
, M. MATSUKURA
, et al.
·
ChemInform
ChemInform Abstract: Synthesis and Cardiovascular Activity of Phenylalkylamine Derivatives. Part 1. Potential Specific Bradycardic Agents.
1993
·
F. OZAKI
, M. MATSUKURA
, et al.
·
ChemInform
Show more works
View as search
Works count:
25
Citation count:
1,516
H-index:
12
I10-index:
13
Year
Topic
Type